You are here: Home / Protocols / Pancreatic Reference Set Application: Ivan Blasutig-University of Toronto (2014)
Team Project

Pancreatic Reference Set Application: Ivan Blasutig-University of Toronto (2014)

389
Blasutig, IvanUniversity of Toronto
Feng, ZidingFred Hutchinson Cancer Research Center
CA19-9, CA125, CUZD16, LAMC2, AGR2, SYCN, and Reg1B
Proteomics
G.I. and Other Associated Cancers Research Group

The primary objective of this study is to independently validate a panel of serum biomarkers for the early detection of pancreatic ductal adenocarcinoma (PDAC). The biomarkers were identified in various discovery studies performed in our laboratory1-6. We hypothesize that our candidate biomarkers can be used as a panel that will perform better than CA19.9 alone for the early detection of PDAC. Such a panel has the potential to lead to improved patient outcomes by enabling patients to receive treatment as early as possible.

We hypothesize that our candidate biomarkers can be used as a panel that will perform better than CA19.9 alone for the early detection of PDAC
Comparisons of marker levels between groups were performed using the Mann Whitney-Wilcoxon test. Mean level comparisons were performed using a t-test and/or an ANOVA test.

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


🔜 Data-Sci Workshop
The EDRN Biomarker Data Science Workshop is coming this August, 2020. More details available soon.
Announcement 03/17/2020

The EDRN Registration page will be available soon to register for the 35th EDRN Steering Committee Meeting, now scheduled to take place from June 30-July 2, 2020, in Tempe, AZ.
Announcement



 
This icon signifies that something is happening and we kindly ask you to please wait